Search Results 441-450 of 16071 for pharmacogenetics

  1. A Study of the Effects of a Nocturnal Rise in Cortisol on Glucose Production in Type 2 Diabetes - Mayo Clinic

    Inclusion Criteria. 30-75 years of age; A body mass index (BMI) of 27-40 kg/m2; Groups of healthy controls and type 2 diadetic patients will be matched for ...

  2. Microbiomics Program - Center for Individualized Medicine - Mayo Clinic Research

    What can the microbiome reveal about health? Can microbial communities in the colon be the cause for irritable bowel symptoms? How do gut microbes affect other ...

  3. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Type: Fellowship; Duration: 1-2 years; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...

  4. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation - Mayo Clinic

    Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage ...

  5. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

    About this study. The purpose of this study is to assess the safety, tolerability, and dose-limiting toxicities (DLTs) and to determine a recommended phase ...

  6. Detection and Identification of Bacterial and Fungal DNA in Blood - Mayo Clinic

    This study includes collection of blood samples from the healthy controls and those with suspected bloodstream infections. Participation eligibility.

  7. Publications - Ernest P. Bouras, M.D. - Mayo Clinic

    ... pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. Epub 2012 Feb 10. View PubMed; Almansa C, Heckman MG, DeVault KR, Bouras E, Achem SR ...

  8. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

  9. An Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse (TGD) Patients - Mayo Clinic

    The purpose of this study is to evaluate the longitudinal changes in lung volumes and spirometry parameters, after both masculinizing and feminizing hormone ...

  10. Transforming Non-Invasive Liver Disease Detection by Magnetic Resonance Elastography - Mayo Clinic

    About this study. A variety of liver insults lead to pathological changes in liver architecture that culminate in cirrhosis. While invasive liver biopsy was ...